ReliefBand is a wrist-worn electrical stimulation device designed to help manage nausea without taking an anti-nausea medication. It delivers adjustable electrical stimulation over the P6 area on the underside of the wrist, a site that has also been studied in broader acupressure and electrical-stimulation research.
There is legitimate regulatory and clinical history behind the technology, including FDA-cleared ReliefBand generations and some independent research involving P6 electrical stimulation. The important limitation is that not every study tested the current Reliefband models sold today, and evidence strength varies by nausea cause.
By Fitness Guru, certified health and wellness writer – Fact-checked and reviewed by our editorial team.
That makes ReliefBand more credible than a simple wellness gadget, but it does not make it a guaranteed solution. The better question is whether the available evidence resembles your type of nausea closely enough to justify the cost, setup, tingling sensation, and possibility of limited benefit.
Quick Verdict
ReliefBand is a reasonable non-drug option to consider for certain nausea situations, especially when its FDA-cleared indications and existing P6 electrical-stimulation research overlap with the reader’s use case. It is also different from passive acupressure wristbands because it actively delivers electrical stimulation rather than pressure alone.
However, the evidence should be interpreted carefully. Some research involves older ReliefBand generations, while other studies evaluate PC6 electrical stimulation more broadly rather than the current Reliefband Premier or Premier+ specifically. ReliefBand should therefore be viewed as a symptom-management tool with variable individual response, not as a guaranteed cure or a substitute for medical care.
What Is ReliefBand?
ReliefBand is a wearable device that applies electrical stimulation to the underside of the wrist around the P6, or PC6, region. The stimulation is intended to activate the median-nerve area associated with that wrist location.
FDA documentation for earlier ReliefBand generations describes the technology as transcutaneous electrical nerve stimulation delivered at the wrist. The FDA’s ReliefBand 2.0 device summary describes adjustable electrical stimulation delivered through wrist contacts and placement over the P6 region.
Current Reliefband products are not all identical. The manufacturer currently sells multiple versions, including Premier+, Premier, Sport, Flex, and Classic. Features such as battery design, intensity controls, display, runtime, and other hardware details can vary between models, so it is inaccurate to treat every ReliefBand generation as one interchangeable device.
How Does ReliefBand Claim to Work?
The manufacturer describes ReliefBand as stimulating the median-nerve area at the P6 point using electrical pulses. Its explanation goes further by describing signals traveling through neural pathways associated with nausea control.
The more cautious interpretation is that the device electrically stimulates the P6/median-nerve region. That part is well documented in FDA device materials. Stronger explanations about exactly how that stimulation changes nausea signaling should be treated as a proposed mechanism rather than as a fully settled explanation for every user and every nausea cause.
This distinction matters because an appealing mechanism does not automatically prove clinical benefit. The useful question is whether controlled studies show meaningful symptom improvement in situations similar to the one you are dealing with.
ReliefBand Evidence: What Is Direct and What Is Indirect?
The easiest way to understand the evidence is to separate four different levels that are often blended together in product marketing.
- Manufacturer statements: These explain how current Reliefband products are designed, used, and marketed.
- FDA-cleared indications: These establish the regulatory indications and device descriptions for specific ReliefBand generations.
- General P6 or PC6 evidence: These studies examine pressure or electrical stimulation at the wrist point, but may not test ReliefBand itself.
- ReliefBand-specific research: These studies directly test a ReliefBand device in a defined clinical setting.
Those categories are related, but they are not interchangeable. Evidence that PC6 stimulation can help in one medical setting does not prove that every current ReliefBand model will produce the same effect in every type of nausea.
FDA Clearance: What It Does and Does Not Mean
ReliefBand has a genuine FDA device history. The FDA 510(k) clearance for ReliefBand 1.5 and 2.0 includes nausea, vomiting, and retching associated with several situations, including motion sickness, chemotherapy, pregnancy-related morning sickness, and postoperative use. The clearance also contains expanded indication language involving other physician-diagnosed conditions.
That regulatory history is meaningful because ReliefBand is not merely a passive bracelet with vague wellness claims. At the same time, FDA clearance should not be interpreted as proof that every current commercial model has been independently tested across every listed situation or that all users will respond similarly.
Regulatory indication and clinical effectiveness are separate questions. The first tells you what the cleared device is intended for. The second depends on the quality, size, relevance, and directness of the available studies.
ReliefBand-Specific Clinical Evidence
One of the more relevant pieces of independent evidence directly involving ReliefBand comes from a randomized study of women undergoing gynecological laparoscopy. In that study, active P6 acustimulation with ReliefBand was compared with sham treatment.
The randomized postoperative ReliefBand study involved 62 patients and reported lower measures of postoperative nausea and vomiting, along with lower antiemetic requirements during several assessed periods in the active-treatment group.
This is useful product-specific evidence, but its scope is narrow. It studied a small postoperative population rather than people using ReliefBand for motion sickness, pregnancy-related nausea, chronic nausea, or routine home use.
It also fits an important regulatory boundary: postoperative ReliefBand use has been described as an adjunct to antiemetic treatment. That is very different from saying the device should replace standard postoperative nausea medications.
What About Chemotherapy-Related Nausea?
Electrical stimulation at PC6 has also been studied in people receiving chemotherapy. A systematic review and meta-analysis of PC6 electrical stimulation during chemotherapy found evidence that stimulation may improve some acute nausea and vomiting outcomes, although not every measured outcome showed a clear benefit.
This supports the broader intervention concept, but it should not be presented as a clinical trial of the current Reliefband Premier. The evidence is more indirect than that.
For people undergoing chemotherapy, this distinction is especially important. The National Cancer Institute’s guidance on nausea during cancer treatment explains that complementary approaches such as acupressure may be used alongside medication and that symptom management should be coordinated with the cancer care team.
ReliefBand may therefore make sense as an adjunctive symptom-management option for some patients, but it should not replace prescribed antiemetic therapy.
Does ReliefBand Work for Morning Sickness?
Pregnancy-related nausea appears in the FDA-cleared indication history for ReliefBand generations, which gives the device a legitimate regulatory basis in this setting. That does not mean every pregnant person should automatically use it or that it will work equally well for everyone.
Pregnancy nausea exists on a wide spectrum. Some people have mild morning sickness, while others develop symptoms severe enough to affect hydration, nutrition, weight, or daily functioning.
ACOG guidance on nausea and vomiting of pregnancy describes established treatment options such as vitamin B6 and doxylamine and emphasizes medical evaluation when symptoms are severe or may have another cause.
For that reason, ReliefBand is better considered one possible non-drug symptom-management tool rather than a replacement for obstetric assessment or established treatment when symptoms are significant.
Does ReliefBand Work for Motion Sickness?
Motion sickness is included in ReliefBand’s FDA-cleared indication history, so using the device in this setting is consistent with its regulatory background.
What the current evidence pack does not establish is that motion sickness is definitively the strongest evidence category for the current Premier model. That claim would require stronger head-to-head evidence comparing conditions and modern models.
A practical way to think about motion-sickness use is this: if your nausea is predictable, such as during car, boat, or air travel, ReliefBand gives you a reusable, adjustable non-drug approach that can be applied before or during the triggering situation. Whether that benefit is large enough for you personally remains uncertain until you actually respond to the stimulation.
ReliefBand vs Passive Acupressure Wristbands
These products are often grouped together, but they are not the same intervention.
Passive acupressure wristbands apply physical pressure over the P6 area. ReliefBand delivers electrical stimulation through wrist contacts.
Because the mechanisms differ, evidence for one category should not automatically be transferred to the other. A study of passive pressure does not prove that an electrical device works, and a study of electrical stimulation does not prove that a simple pressure band will produce the same result.
This distinction is especially important when comparing low-cost acupressure bands with ReliefBand. The cheaper device may appeal to the same buyer, but it is not a direct technological equivalent.
Current Reliefband Premier: Practical Features
Because Reliefband currently sells several models, it is more useful to discuss verified specifications for a named current model rather than describing every ReliefBand device as though it has the same hardware.
For the current Reliefband Premier, the manufacturer lists 10 stimulation levels and a rechargeable battery. It states approximately 18 hours of use on a full charge, depending on operating conditions. The current Premier package also includes conductivity gel and a charging cable, and the listed wrist-fit range is approximately 5.5 to 9.5 inches.
Those are Premier-specific current manufacturer details. They should not be assumed to apply to older ReliefBand models or every other current version.
How Do You Use ReliefBand?
Current manufacturer instructions tell users to wear the device on the underside of either wrist, between the two tendons, roughly two finger widths from the wrist crease.
Conductivity gel is applied to the wrist area before positioning the contacts. The stimulation level is then increased until the user feels a comfortable tingling sensation that can extend into the palm or middle-finger region.
The manufacturer also advises reapplying gel when stimulation becomes less noticeable and gives a general reapplication interval of about two to three hours in its current guidance.
Placement matters. If the contacts are not positioned correctly or the skin contact is poor, the stimulation may not be delivered as intended.
What Does the Stimulation Feel Like?
ReliefBand is not passive. You should expect to feel the stimulation.
The manufacturer describes the intended sensation as a comfortable tingling. Some people may find that sensation easy to tolerate, while others may find electrical stimulation distracting or unpleasant.
The adjustable intensity gives the user some control, but higher intensity should not be treated as automatically more effective. The practical goal is proper placement and a tolerable stimulation level rather than simply turning the device up as high as possible.
Does ReliefBand Require Conductivity Gel?
For current Reliefband instructions, yes. Conductivity gel is part of the setup because it helps the device maintain effective electrical contact with the skin.
This matters for ownership because ReliefBand is not simply a charge-and-wear device. Gel application becomes part of the routine, and replacement gel can add a small ongoing maintenance requirement.
If you dislike carrying gel, reapplying it, or managing skin preparation, that practical inconvenience may matter more than the technical specifications.
Pros and Cons of ReliefBand
| Potential Advantages | Potential Drawbacks |
|---|---|
| Non-drug symptom-management approach | Individual response can vary |
| FDA-cleared device history for several nausea contexts | Evidence does not map equally well to every current model or nausea cause |
| Electrical stimulation rather than passive pressure | The tingling sensation may not suit everyone |
| Adjustable stimulation intensity | Correct wrist placement matters |
| Current Premier model is rechargeable | Charging and battery management add another step |
| Reusable hardware | Conductivity gel is part of ongoing use |
| Some ReliefBand-specific and broader PC6 clinical evidence exists | Current Premier performance is not proven by every older ReliefBand or PC6 study |
Who Is Most Likely to Find ReliefBand Worth Considering?
ReliefBand makes the most sense when its benefits line up with a repeatable problem rather than an occasional episode that may never justify buying and maintaining a device.
You may find it worth investigating if your nausea occurs repeatedly in a context connected to its regulatory or research history, you want to reduce reliance on medication when medically appropriate, and you are comfortable wearing a device that produces noticeable electrical stimulation.
It may also appeal to someone who travels frequently and deals with predictable motion-related symptoms, or to a patient who wants to discuss an adjunctive non-drug nausea tool with a clinician.
Who May Be Better Off Skipping It?
ReliefBand may be harder to justify if your nausea is rare, mild, or easily managed with simpler strategies. The cost and setup become less attractive when the device would only be used occasionally.
It may also be a poor fit if you strongly dislike tingling sensations, do not want to apply conductivity gel, or prefer a simpler passive device even if that means using a different intervention.
Most importantly, persistent, unexplained, worsening, or medically significant nausea should not be treated as a shopping problem. A wrist device can only address symptoms; it cannot diagnose or treat the underlying cause.
What About User Reviews and Real-World Experiences?
ReliefBand has many online reviews, including reviews hosted by the manufacturer, but a reproducible independent analysis across major retailers and discussion platforms was not established for this review.
That means it would be misleading to claim that hundreds of reviews were analyzed, to divide users into precise sentiment groups, or to present composite testimonials as though they were verified quotations from representative customers.
Individual reviews can still be useful for understanding practical issues such as sensation, placement, gel use, travel convenience, and charging. They should not be used as proof that the device is clinically effective.
ReliefBand Claim vs Evidence: A Practical Buyer Framework
If you are trying to decide whether ReliefBand is worth trying, use four questions rather than relying on marketing language alone.
1. What Is Causing Your Nausea?
Evidence becomes more relevant when your situation resembles the population or condition that was actually studied. Postoperative nausea, chemotherapy-related nausea, pregnancy-related nausea, and motion sickness should not be treated as one interchangeable condition.
2. Is the Evidence Directly About ReliefBand?
Some studies involve ReliefBand itself. Others examine electrical stimulation at PC6 more generally. Both can be informative, but direct product evidence deserves more weight when judging the commercial device.
3. Does the Study Match the Current Model?
Older ReliefBand generations and current products are not necessarily identical. A result from an older device should not automatically be presented as proof of exact Premier or Premier+ performance.
4. Would You Use It Often Enough to Justify the Cost and Routine?
Even a device with plausible benefit may be poor value for someone who experiences nausea only once or twice a year. Frequent travelers or people dealing with recurring symptoms may view the economics differently.
Is ReliefBand Worth the Money?
There is no universal answer because value depends on how often you would use it, what alternatives are available to you, and how much uncertainty you are comfortable accepting.
ReliefBand offers more than a passive pressure band: it delivers adjustable electrical stimulation, has an FDA-cleared device history, and has at least some ReliefBand-specific clinical evidence. Those points support taking it seriously.
On the other hand, the evidence is not broad enough to promise reliable benefit for every nausea cause, and not every historical study can be mapped directly to current Premier hardware.
The value proposition is therefore strongest for someone with recurring nausea in a relevant use case, a preference for a non-drug option, and enough expected use to justify a higher upfront cost. It is weaker for occasional nausea, poorly understood symptoms, or anyone expecting a guaranteed result.
Safety and Medical Considerations
ReliefBand should be viewed as a symptom-management device, not as a way to avoid medical assessment when nausea may signal something more serious.
Seek medical guidance if nausea is persistent, severe, unexplained, associated with dehydration or inability to keep fluids down, connected to pregnancy complications, occurring during cancer treatment, or accompanied by other concerning symptoms.
If you use a pacemaker or another implanted electronic device, do not rely on broad internet claims about compatibility. Check the current instructions and contraindications for the exact Reliefband model you are considering and ask your clinician when appropriate.
Likewise, current evidence does not justify a blanket statement that ReliefBand is universally safe for every pregnant user, every medical condition, or every medication plan.
About the Author
Fitness Guru is a certified health and wellness writer with over 7 years of experience in evidence-based fitness, nutrition, and lifestyle content. As the lead author of Go4HealthnFitness.com, she’s passionate about simplifying science-backed wellness advice for everyday readers. When she’s not writing, you’ll find her strength training, hiking, or exploring natural supplements that actually work.
Editorial Process Note
Our Commitment to Accuracy: This article was medically reviewed for accuracy and fact-checked by our editorial team.
Medical Disclaimer: The information in this article is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Frequently Asked Questions
Does ReliefBand work for motion sickness?
Motion sickness is part of ReliefBand’s FDA-cleared indication history. That makes the use case legitimate, but the current evidence pack does not prove that every modern Reliefband model works equally well for every person with motion sickness.
Pregnancy-related morning sickness appears in FDA-cleared ReliefBand indication history. However, pregnancy nausea can range from mild to medically significant, so ReliefBand should not replace obstetric evaluation or established treatment when symptoms are severe.
How is ReliefBand different from an acupressure wristband?
Passive acupressure bands apply pressure to the P6 area. ReliefBand delivers electrical stimulation. Because they use different interventions, evidence for one category should not automatically be treated as evidence for the other.
How quickly does ReliefBand work?
A universal 5- to 15-minute onset was not adequately verified for this review. The manufacturer markets ReliefBand as a fast-acting device, but the exact onset and degree of relief may vary by person, condition, model, and study context.
Do you need conductivity gel?
Current manufacturer instructions for Reliefband devices such as Premier include conductivity gel as part of proper use. The gel helps maintain electrical contact between the device and skin.
Can ReliefBand replace anti-nausea medication?
Not generally. In settings such as chemotherapy or postoperative nausea, the evidence and guidance support viewing P6 stimulation as an adjunctive option rather than an automatic replacement for standard antiemetic treatment.
When should nausea be medically assessed instead of self-managed?
Medical assessment becomes more important when nausea is severe, persistent, unexplained, associated with dehydration or significant weight or fluid problems, occurs during pregnancy or cancer treatment, or comes with other concerning symptoms.
Final Verdict
ReliefBand is not just a passive wellness bracelet. It has an FDA-cleared device history, uses active electrical stimulation at the P6 wrist region, and is supported by a mix of ReliefBand-specific research and broader evidence on PC6 electrical stimulation.
The limitation is not that there is no evidence. The limitation is that the evidence is uneven. Some studies are condition-specific, some involve earlier ReliefBand generations, and some examine electrical P6 stimulation rather than the current commercial device.
That makes ReliefBand most reasonable for readers whose nausea closely matches a studied or cleared use case, who prefer a non-drug option, and who are comfortable with electrical tingling, conductivity gel, charging, and uncertain individual response.
If your nausea is persistent, unexplained, severe, or connected to pregnancy, chemotherapy, surgery, or another medical condition, the better first question is not whether to buy a wrist device. It is whether the underlying symptom is being evaluated and managed appropriately.
Don’t Miss These Picks